HUMAN PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HUMAN PHARMA
Largest movements
- Receivables within one year -€83,633
down €83,633 (-21.2%), from €394,343 to €310,710
of which Trade receivables: -€84,756
- Tangible fixed assets -€7,793
down €7,793 (-18.0%), from €43,234 to €35,441
of which Plant, machinery and equipment: -€7,041
- Cash -€7,186
down €7,186 (-47.8%), from €15,020 to €7,833
mainly Trade debts (-€101,406) and Current portion of long-term debt (-€29,458)
- Trade debts -€101,406
down €101,406 (-56.5%), from €179,421 to €78,016
- Profit (loss) carried forward +€46,829
up €46,829 (+26.8%), from €175,011 to €221,840
- Current portion of long-term debt -€29,458
down €29,458 (-73.9%), from €39,858 to €10,400
- Tax, wage and social debts -€13,354
down €13,354 (-43.0%), from €31,077 to €17,723
of which Taxes: -€13,528
- Advances received +€11,182
up €11,182 (+12.7%), from €87,930 to €99,112
- Purchases and services +€131,388
up €131,388 (+14.6%), from €898,026 to €1.0m
- Gross operating margin -€47,403
down €47,403 (-29.3%), from €161,960 to €114,557
- Taxes -€8,646
down €8,646 (-38.3%), from €22,601 to €13,955
- Other operating charges -€4,370
down €4,370 (-68.3%), from €6,396 to €2,025
- Staff costs +€2,709
up €2,709 (+9.0%), from €30,257 to €32,965
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €538,385 | €434,132 | -€104,253 | -19.4% |
| Fixed assets | 21/28 | €65,234 | €54,691 | -€10,543 | -16.2% |
| Intangible fixed assets | 21 | €22,000 | €19,250 | -€2,750 | -12.5% |
| Tangible fixed assets | 22/27 | €43,234 | €35,441 | -€7,793 | -18.0% |
| Plant, machinery and equipment | 23 | €36,459 | €29,418 | -€7,041 | -19.3% |
| Furniture and vehicles | 24 | €6,775 | €6,024 | -€752 | -11.1% |
| Current assets | 29/58 | €473,150 | €379,440 | -€93,710 | -19.8% |
| Stocks and contracts in progress | 3 | €63,787 | €60,897 | -€2,890 | -4.5% |
| Stocks | 30/36 | €63,787 | €60,897 | -€2,890 | -4.5% |
| Amounts receivable within one year | 40/41 | €394,343 | €310,710 | -€83,633 | -21.2% |
| Trade receivables | 40 | €294,460 | €209,704 | -€84,756 | -28.8% |
| Other amounts receivable | 41 | €99,883 | €101,006 | +€1,123 | +1.1% |
| Cash at bank and in hand | 54/58 | €15,020 | €7,833 | -€7,186 | -47.8% |
| Total equity and liabilities | 10/49 | €538,385 | €434,132 | -€104,253 | -19.4% |
| Equity | 10/15 | €178,011 | €224,840 | +€46,829 | +26.3% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €175,011 | €221,840 | +€46,829 | +26.8% |
| Provisions and deferred taxes | 16 | €9,000 | - | -€9,000 | |
| Provisions for liabilities and charges | 160/5 | €9,000 | - | -€9,000 | |
| Other liabilities and charges | 164/5 | €9,000 | - | -€9,000 | |
| Amounts payable | 17/49 | €351,374 | €209,292 | -€142,082 | -40.4% |
| Amounts payable after more than one year | 17 | €13,088 | €2,688 | -€10,400 | -79.5% |
| Financial debts | 170/4 | €13,088 | €2,688 | -€10,400 | -79.5% |
| Amounts payable within one year | 42/48 | €338,286 | €206,604 | -€131,682 | -38.9% |
| Current portion of amounts payable after more than one year | 42 | €39,858 | €10,400 | -€29,458 | -73.9% |
| Financial debts | 43 | - | €1,354 | +€1,354 | |
| Credit institutions | 430/8 | - | €1,354 | +€1,354 | |
| Trade debts | 44 | €179,421 | €78,016 | -€101,406 | -56.5% |
| Suppliers | 440/4 | €179,421 | €78,016 | -€101,406 | -56.5% |
| Advances received on contracts in progress | 46 | €87,930 | €99,112 | +€11,182 | +12.7% |
| Taxes, remuneration and social security | 45 | €31,077 | €17,723 | -€13,354 | -43.0% |
| Taxes | 450/3 | €27,483 | €13,955 | -€13,528 | -49.2% |
| Remuneration and social security | 454/9 | €3,594 | €3,768 | +€174 | +4.9% |
| Goods, raw materials, services and sundry goods | 60/61 | €898,026 | €1,029,414 | +€131,388 | +14.6% |
| Remuneration, social security and pensions | 62 | €30,257 | €32,965 | +€2,709 | +9.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,628 | €13,525 | +€896 | +7.1% |
| Other operating charges | 640/8 | €6,396 | €2,025 | -€4,370 | -68.3% |
| Non-recurring operating charges | 66A | €63 | €143 | +€80 | +127.3% |
| Gross operating margin | 9900 | €161,960 | €114,557 | -€47,403 | -29.3% |
| Operating profit (loss) | 9901 | €112,616 | €65,898 | -€46,718 | -41.5% |
| Financial income | 75/76B | €238 | €88 | -€150 | -63.1% |
| Recurring financial income | 75 | €238 | €88 | -€150 | -63.1% |
| Financial charges | 65/66B | €5,494 | €5,203 | -€292 | -5.3% |
| Recurring financial charges | 65 | €5,494 | €5,203 | -€292 | -5.3% |
| Profit (loss) for the period before taxes | 9903 | €107,361 | €60,784 | -€46,577 | -43.4% |
| Income taxes | 67/77 | €22,601 | €13,955 | -€8,646 | -38.3% |
| Profit (loss) for the period | 9904 | €84,759 | €46,829 | -€37,930 | -44.8% |
| Profit (loss) for the period to be appropriated | 9905 | €84,759 | €46,829 | -€37,930 | -44.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.